AUB
OVID icon

Atlantic Union Bankshares’s Ovid Therapeutics OVID Stock Holding History

Atlantic Union Bankshares’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.19K Hold
2,300
– – ﹤0.01% 1413
2026
Q1 		$5.11K Hold
2,300
– – ﹤0.01% 1422
2025
Q4 		$3.75K Hold
2,300
– – ﹤0.01% 1430
2025
Q3 		$2.99K Hold
2,300
– – ﹤0.01% 1440
2025
Q2 		$759 Buy
+2,300
New +$693 ﹤0.01% 1140

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Atlantic Union Bankshares's OVID Position: Q2 2026 in Review

Atlantic Union Bankshares held its Ovid Therapeutics (OVID) position steady in Q2 2026 at 2,300 shares worth $6.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1413.

Atlantic Union Bankshares first reported a position in OVID in Q2 2025 and has held it in 5 quarters since. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • Atlantic Union Bankshares held 2,300 shares of Ovid Therapeutics worth $6.19K as of Q2 2026.
  • Atlantic Union Bankshares left its Ovid Therapeutics share count unchanged in Q2 2026.
  • Ovid Therapeutics made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #1413 holding.
  • Atlantic Union Bankshares first reported a position in Ovid Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.